This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Codexis, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Niusha Mahmoodi: Innovator in Polynucleotide Synthesis
Introduction
Niusha Mahmoodi is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of biotechnology, particularly in the area of polynucleotide synthesis. Her innovative work has led to the development of engineered terminal deoxynucleotidyl transferase variants, which have important applications in genetic research and therapeutic development.
Latest Patents
Niusha Mahmoodi holds 1 patent for her invention titled "Engineered terminal deoxynucleotidyl transferase variants." This invention provides engineered terminal deoxynucleotidyl transferase (TdT) polypeptides that are useful in template-independent polynucleotide synthesis. The invention utilizes a nucleoside triphosphate-3'-O-removable blocking group (NTP-3′-O-RBG), along with compositions and methods for utilizing these engineered polypeptides, as well as polynucleotides encoding the engineered terminal deoxynucleotidyl transferases.
Career Highlights
Niusha Mahmoodi is currently employed at Codexis, Inc., where she continues to advance her research and development efforts. Her work at Codexis has positioned her as a key player in the biotechnology sector, contributing to innovative solutions that address complex challenges in genetic engineering.
Collaborations
Niusha collaborates with talented professionals in her field, including Charlene Ching and Stephanie Marie Forget. These collaborations enhance her research capabilities and foster a dynamic environment for innovation.
Conclusion
Niusha Mahmoodi is a trailblazer in the field of biotechnology, with her patented innovations paving the way for advancements in polynucleotide synthesis. Her contributions are vital to the ongoing evolution of genetic research and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
